Headlines

Neuraxpharm launches new multiple sclerosis treatment in Europe

Neuraxpharm Group, a European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has announced the first launch of BRIUMVI (ublituximab) in Europe for the treatment of adult patients with relapsing multiple...

Global Industry News

Hot Topics

Spotlight

Follow us

Webinars

Featured Suppliers

All